Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats

Journal of Molecular Endocrinology

Volumn 35, Issue 1, 2005, Pages 27-38

  Sancho, Verónica ^b   Trigo, María V ^b   González, Nieves ^b   Valverde, Isabel ^b   Malaisse, Willy J ^a   Villanueva Peñacarrillo, María L ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; DEOXYGLUCOSE; EXENDIN 4; EXENDIN 9; GASTROINTESTINAL HORMONE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PROTEIN P42; PROTEIN P44; RAPAMYCIN; S6 KINASE; STREPTOZOCIN; UNCLASSIFIED DRUG; WORTMANNIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE TRANSPORT; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; LIPID METABOLISM; LIPIDS; LIPOLYSIS; MALE; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN KINASES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; VENOMS;

EID: 23844526330     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01747     Document Type: Article

References (47)

1. Acitores A, González N, Sancho V, Valverde I & Villanueva-Peñacarrillo ML 2004 Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. Journal of Endocrinology 180 389-398.
2. Alcántara AI, Morales M, Delgado E, López-Delgado MI, Clemente F, Luque MA, Malaisse WJ, Valverde I & Villanueva-Peñacarrillo ML 1997 Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle. Archives of Biochemistry and Biophysics 341 1-7.
3. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 72 248-254.
4. Bullock BP, Heller RS & Habener JF 1996 Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137 2968-2978.
5. Cancelas J, Villanueva-Peñacarrillo ML, Valverde I & Malaisse WJ 2001a Synergistic insulinotropic effects of succinic acid dimethyl ester and exendin-4 in anesthetized rats. International Journal of Molecular Medicine 8 269-271.
6. Cancelas J, Villanueva-Peñacarrillo ML, Valverde I & Malaisse WJ 2001b Suppression by exendin(9-39)amide of glucagon-like peptide 1 insulinotropic action in rats infused with the dimethyl ester of succinic acid. Endocrine 15 283-285.
7. Creutzfeldt W 2001 The entero-insular axis in type-2 diabetes. Incretins as therapeutic agents. Experimental and Clinical Endocrinology and Diabetes 109 S288-S303.
8. D'Alessio DA, Prigeon RL & Ensinck JW 1995 Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide 1. Diabetes 44 1433-1437.
9. Dardevet D, Moore MC, Neal D, DiCostanzo CA, Snead W & Cherrington AD 2004 Insulin independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. American Journal of Physiology, Endocrinology and Metabolism 287 E75-E81.
10. Davies SP, Reddy H & Caivano M 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal 351 95-105.
11. Delgado E, Luque MA, Alcántara A, Trapote MA, Clemente F, Galera C, Valverde I & Villanueva-Peñacarrillo ML 1995 Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides 16 225-229.
12. González N, Sancho V, Acitores A, Martín-Duce A, Valverde I & Villanueva-Peñacarrillo ML 2004 Signalling in the GLP-1 and exendins action on glucose transport in myocytes from type-2 diabetic patients. Diabetologia 47 (Suppl 1) A37-A38.
13. González N, Acitores A, Sancho V, Valverde I & Villanueva-Peñacarrillo ML 2005 Effect of GLP-1 on glucose transport and its cell signaling in human myocytes. Regulatory Peptides 126 203-211.
14. Gutniak M, Orskov C, Holst JJ, Ahrén B & Efendic S 1992 Antidiabetogenic effects of glucagon-like peptide-1(7-36)amide in normal subjects and patients with diabetes mellitus. New England Journal of Medicine 326 1316-1322.
15. Hedeskov CJ, Capito K, Islin H, Hansen SE & Thams P 1992 Long-term fat-feeding-induced insulin resistance in normal NMRI mice: postreceptor changes of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes. Acta Diabetologica 29 14-19.
16. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 680-685.
17. Lange A, Bak J, Andersen PH, Richelsen B & Pedersen O 1988 A mixed meal potentiates the insulin sensitivity of glucose transport and metabolism in adipocytes from patients with type 2 diabetes mellitus. Diabetic Medicine 5 761-765.
18. López-Delgado MI, Morales M, Villanueva-Peñacarrillo ML, Malaisse WJ & Valverde I 1998 Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase α in hepatocytes from normal and diabetic rats. Endocrinology 139 2811-2817.
19. Luque MA, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I & Villanueva-Peñacarrillo ML 2002 GLP-1 and glucose metabolism in human myocytes. Journal of Endocrinology 173 465-473.
20. Markuns JF, Napoli R, Hirshman MF, Davalli AM, Cheatham B & Goodyear LJ 1999 Effects of streptozocin-induced diabetes and islet cell transplantation on insulin signaling in rat skeletal muscle. Endocrinology 140 106-111.
21. Meneilly G, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Finegood DT & Elahi D 2001 Effects of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes Care 24 1951-1956.
22. Mérida E, Delgado E, Molina LM, Villanueva-Peñacarrillo ML & Valverde I 1993 Presence of glucagon and glucagon-like peptide-1(7-36)amide receptors in solubilized membranes of human adipose tissue. Journal of Clinical Endocrinology and Metabolism 77 1654-1657.
23. Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H & Klein HH 2002 Insulin signalling in skeletal muscle of subjects with or without type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45 813-822.
24. Miki H, Namba M, Nishimura T, Mineo I, Matsumara T, Miyagawa J, Nakajima H, Kuwajima M, Hanafusa T & Matsuzawa Y 1996 Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes. Biochimica et Biophysica Acta 1312 132-136.
25. Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH & Adams LG 1997 Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. Journal of Cellular Physiology 172 275-283.
26. Morales M, López-Delgado MI, Alcántara A, Luque MA, Clemente F, Márquez L, Puente J, Viñambres C, Malaisse WJ, Villanueva-Peñacarrillo ML & Valverde I 1997 Preserved GLP-1 effects upon glycogen synthase α activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats. Diabetes 46 1264-1269.
27. Nielsen LL, Young AA & Parkes DG 2004 Pharmacology of exenatide (synthetic exedin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regulatory Peptides 117 77-88.
28. Peak M, Rochford JJ, Borthwick AC, Yeaman SJ & Agius L 1998 Signalling pathways involved in the stimulation of glycogen synthesis by insulin in rat hepatocytes. Diabetologia 41 16-25.
29. Perea A, Clemente F, Martinell J, Villanueva-Peñacarrillo ML & Valverde I 1995 Physiological effect of glucagon in human isolated adipocytes. Hormone and Metabolic Research 27 372-375.
30. Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML & Valverde I 1997 GLP-1(7-36)amide effects on glucose transport and metabolism in rat adipose tissue. Hormone and Metabolic Research 9 417-421.
31. Portha B, Picon L & Rosselin G 1979 Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17 371-377.
32. Redondo A, Trigo MV, Acitores A, Valverde I & Villanueva-Peñacarrillo ML 2003 Cell signalling of the GLP-1 action in rat liver. Molecular and Cellular Endocrinology 204 43-50.
33. Rodbell M 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. Journal of Biological Chemistry 239 375-380.
34. Ruiz-Grande C, Alarcón C, Mérida E & Valverde I 1992 Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides 13 13-16.
35. Thorens B 1992 Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide-1. PNAS 89 8641-8645.
36. Valverde I, Mérida E, Delgado E, Trapote MA & Villanueva-Peñacarrillo ML 1993 Presence and characterization of glucagon-like peptide-1(7-36)amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132 75-79.
37. Valverde I, Morales M, Clemente F, López-Delgado MI, Delgado E, Perea A & Villanueva-Peñacarrillo ML 1994 Glucagon-like peptide-1: a potent glycogenic hormone. FEBS Letters 349 313-316.
38. Vicent D, Villanueva-Peñacarrillo ML, Valverde I & Malaisse WJ 1994 Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin. Acta Diabetologica 31 133-137.
39. Villanueva-Peñacarrillo ML, Alcántara A, Clemente F, Delgado E & Valverde I 1994 Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 37 1163-1166.
40. Villanueva-Peñacarrillo ML, Delgado E, Trapote MA, Alcántara AI, Clemente F, Luque MA, Perea A & Valverde I 1995 Glucagon-like peptide-1 binding to rat hepatic membranes. Journal of Endocrinology 146 183-189.
41. Villanueva-Peñacarrillo ML, Márquez L, González N, Díaz-Miguel M & Valverde I 2001a Effect of GLP-1 on lipid metabolism in human adipocytes. Hormone and Metabolic Research 33 73-77.
42. Villanueva-Peñacarrillo ML, Puente J, Redondo A, Clemente F & Valverde I 2001b Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in NIDDM and IDDM rats. Endocrine 15 241-248.
43. Wang Y, Kole HK, Montrose-Rafizadeh C, Perfetti R, Bernier M & Egan JM 1997 Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions. Journal of Molecular Endocrinology 19 241-248.
44. Wieland O 1963 Glycerol. In Methods in Enzymatic Analysis, pp 211-214. Ed HU Bergmeyer. New York: Academic Press.
45. Wilkinson SE, Parker PJ & Nixon JS 1993 Isoenzyme specifity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochemical Journal 294 335-337.
46. Yang H, Egan JM, Wang Y, Moyes D, Roth J, Montrose MH & Montrose-Rafizadeh C 1998 GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor. American Journal of Physiology 275 C675-C683.
47. Yu ZW, Jansson PA, Posner BI, Smith U & Eriksson JW 1997 Peroxovanadate and insulin action in adipocytes from NIDDM patiens. Evidence against a primary defect in tyrosine phosphorylation. Diabetologia 40 1197-1203.